Applying Quality by Design to Granulation Process – A Brief Overview
Since its inception in 2002 by USFDA, the Quality by design (QbD) approach has brought a major shift in pharmaceutical…
Since its inception in 2002 by USFDA, the Quality by design (QbD) approach has brought a major shift in pharmaceutical…
Proteins and peptides, including hormones, monoclonal antibodies, cytokines, vaccines, enzymes and nucleotides, constituted nearly 30% of new molecules approved by…